User profiles for Neil K Jairath
 | Neil JairathVerified email at alumni.nd.edu Cited by 562 |
A systematic review of the evidence for the decipher genomic classifier in prostate cancer
Context Molecular biomarkers aim to address the established limitations of clinicopathologic
factors to accurately risk stratify patients with prostate cancer (PCa). Questions remain as to …
factors to accurately risk stratify patients with prostate cancer (PCa). Questions remain as to …
Integrated survival estimates for cancer treatment delay among adults with cancer during the COVID-19 pandemic
Importance Cancer treatment delay has been reported to variably impact cancer-specific
survival and coronavirus disease 2019 (COVID-19)–specific mortality during the severe acute …
survival and coronavirus disease 2019 (COVID-19)–specific mortality during the severe acute …
Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer
Importance In men with recurrent prostate cancer, addition of long-term antiandrogen
therapy to salvage radiotherapy (SRT) was associated with overall survival (OS) in the NRG/RTOG …
therapy to salvage radiotherapy (SRT) was associated with overall survival (OS) in the NRG/RTOG …
Rapid, label-free detection of diffuse glioma recurrence using intraoperative stimulated Raman histology and deep neural networks
Background Detection of glioma recurrence remains a challenge in modern neuro-oncology.
Noninvasive radiographic imaging is unable to definitively differentiate true recurrence …
Noninvasive radiographic imaging is unable to definitively differentiate true recurrence …
Characterization of the tumor immune microenvironment identifies M0 macrophage-enriched cluster as a poor prognostic factor in hepatocellular carcinoma
M Farha, NK Jairath, TS Lawrence… - JCO Clinical Cancer …, 2020 - ascopubs.org
PURPOSE Hepatocellular carcinoma (HCC) is characterized by a poor prognosis and a high
recurrence rate. The tumor immune microenvironment in HCC has been characterized as …
recurrence rate. The tumor immune microenvironment in HCC has been characterized as …
Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma
NK Jairath, MW Farha, R Jairath, PW Harms… - Melanoma …, 2020 - Future Medicine
… Jairath; investigation by NK Jairath and M Farha; resources provided by NK Jairath and M
Farha; data curation by NK Jairath … was prepared by NK Jairath, M Farha, R Jairath, PW Harms…
Farha; data curation by NK Jairath … was prepared by NK Jairath, M Farha, R Jairath, PW Harms…
[HTML][HTML] Tumor immune microenvironment clusters in localized prostate adenocarcinoma: prognostic impact of macrophage enriched/plasma cell non-enriched …
Background: Prostate cancer (PCa) is characterized by significant heterogeneity in its
molecular, genomic, and immunologic characteristics. Methods: Whole transcriptome RNAseq …
molecular, genomic, and immunologic characteristics. Methods: Whole transcriptome RNAseq …
[HTML][HTML] Gianturco Z-stent placement for the treatment of chronic central venous occlusive disease: implantation of 208 stents in 137 symptomatic patients
…, JJ Bundy, AN Hage, NK Jairath… - Diagnostic and …, 2021 - ncbi.nlm.nih.gov
PURPOSE To report the technical successes, adverse events, and long-term stent patency
rates of Gianturco Z-stents for management of chronic central venous occlusive disease. …
rates of Gianturco Z-stents for management of chronic central venous occlusive disease. …
High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care …
Merkel cell carcinoma (MCC) is a neuroendocrine skin cancer with a high rate of mortality.
While still relatively rare, the incidence of MCC has been rapidly rising in the US and around …
While still relatively rare, the incidence of MCC has been rapidly rising in the US and around …
Local control and toxicity of multilevel spine stereotactic body radiotherapy
WH Beeler, KA Speth, MT Broderick, NK Jairath… - …, 2020 - journals.lww.com
BACKGROUND Spine stereotactic body radiotherapy (sSBRT) is commonly limited to 1 or 2
vertebral levels given a paucity of efficacy and toxicity data when more than 2 levels are …
vertebral levels given a paucity of efficacy and toxicity data when more than 2 levels are …